T cell engineering
The latest breakthrough in cancer therapy allows cell engineers to remove immune cells from a sick patient, add new DNA encoding for anti-tumour functionality into the cells, and reinject those cells back into the patient. While this technology is already showing clinical success, manufacturing pipelines are proving to be especially difficult. In this project we apply microfluidic techniques to immune cell engineering processes in an attempt to miniaturize and automate. Our long term goal is to build a device capable of on-sight immune cell engineering to treat patients directly in the clinic.
Samuel Little, Angela Quach